Giovannelli e Associati has advised H-Farm
21/12/2018
Giovannelli e Associati is advising Azelis on the acquisition of Deafarma S.r.l.
21/12/2018Giovannelli e Associati advised Altheia Science on a capital increase of its corporate capital
il
Giovannelli e Associati advised Altheia Science, a biotech start-up incorporated to develop curative medicine for autoimmune diseases (multiple sclerosis and diabetes) on the capital increase of its corporate capital.
The team of Giovannelli e Associati comprised partner Gianvittorio Giroletti Angeli and associate Matilde Finucci.
Read More:
